tradmap

CNTB Earnings Connect Biopharma Holdings Ltd

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$1 -$1 $0 2023 2024 2025
EPS
Revenue (annual)
$0 $13M $26M 2023 2024 2025
Revenue
Net income (annual)
-$62M -$31M $0 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$1 -$0 $0 $0 Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26
EPS
Revenue (quarterly)
$0 $12M $24M Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue
Net income (quarterly)
-$19M -$2M $15M $0 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26
Net income

Reported EPS history

1–11 of 11
Q2 20262026-06-30-0.612026-08-1210-Q
Q1 20262026-03-31-0.342026-05-1210-Q
FY 20252025-12-31-1.002026-03-3110-K
Q3 20252025-09-30-0.732025-11-1210-Q
Q2 20262025-06-30-0.422026-08-1210-Q
Q1 20262025-03-31-0.192026-05-1210-Q
FY 20252024-12-31-0.282026-03-3110-K
Q3 20252024-09-30-0.122025-11-1210-Q
Q2 20252024-06-300.112025-08-1310-Q
Q1 20252024-03-31-0.162025-05-1510-Q
FY 20242023-12-31-1.132025-03-3110-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.